Hudson Bay Capital Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Hudson Bay Capital Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,391	Closed	-$863K	–	725
2016 Q3	$863K	Hold	8,391	–	–	0.02%	318
2016 Q2	$994K	Sell	8,391 -24,769	-75%	-$2.48M	0.03%	253
2016 Q1	$2.34M	Buy	+33,160	New	+$2.19M	0.11%	89
2015 Q4	–	Sell	-26,312	Closed	-$1.74M	–	242
2015 Q3	$1.74M	Hold	26,312	–	–	0.08%	132
2015 Q2	$2.12M	Sell	26,312 -1,034	-4%	-$84.7K	0.06%	167
2015 Q1	$2.13M	Sell	27,346 -2,231	-8%	-$199K	0.06%	139
2014 Q4	$2.79M	Sell	29,577 -2,442	-8%	-$193K	0.06%	120
2014 Q3	$1.57M	Buy	32,019 +31,060	+3,239%	+$3.44M	0.04%	149
2014 Q2	$122K	Buy	+959	New	+$149K	﹤0.01%	164
2014 Q1	–	Sell	-959	Closed	-$47K	–	203
2013 Q4	$47K	Hold	959	–	–	﹤0.01%	154
2013 Q3	$47K	Buy	+959	New	+$187K	﹤0.01%	166

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

TFCP

Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hudson Bay Capital Management's VBIV Position: Q4 2016 in Review

Hudson Bay Capital Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2016, closing a stake of 8,391 shares — an estimated $863K sold.

Hudson Bay Capital Management first reported a position in VBIV in Q3 2013 and held it in 11 quarters. The position peaked at $2.79M in Q4 2014. 21 funds tracked by Wall St. Rank hold VBIV as of Q4 2016.

Hudson Bay Capital Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2016 after selling out during the quarter.
Hudson Bay Capital Management sold 8,391 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2016, an estimated $863K.
Hudson Bay Capital Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2013 and held it in 11 quarters.
Hudson Bay Capital Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2.79M in Q4 2014.
21 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2016.

Based on Hudson Bay Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.